Evidence map›Paper›PMID 22334212›Full record

ReviewNature reviews. Neuroscience2012

Mechanisms of CaMKII action in long-term potentiation.

John Lisman, Ryohei Yasuda, Sridhar Raghavachari

Abstract readReview
In one paragraph

Review in Nature reviews. Neuroscience, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 650 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
650citing papers in PubMed, 1 pooled it
35.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

650 citing papers in PubMed, 1 synthesis or guideline pooled it, 1,113 citations in OpenAlex.

  1. Pooled it
  2. Enhancement of hippocampal synaptic AMPA receptor function by the antidepressant tianeptine and by opioid peptides.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. ALKBH3 m1A Demethylase Deficiency Reduces Alzheimer's Amyloid-β Pathology.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article

590 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

John LismanDepartment of Biology, Brandeis University, Waltham, Massachusetts 02454, USA. lisman@brandeis.edu
Ryohei Yasuda
Sridhar Raghavachari
Duke University · USBrandeis University · US

Funding

CRCNS: Quantitative description of initial biochemical steps in LTPR01DA027807 · NIDA · BRANDEIS UNIVERSITY · PI LISMAN, JOHN E · 2009 to 2013
$1.6M
NIDA NIH HHS R01 DA027807
6 · The paper itself

Abstract

Long-term potentiation (LTP) of synaptic strength occurs during learning and can last for long periods, making it a probable mechanism for memory storage. LTP induction results in calcium entry, which activates calcium/calmodulin-dependent protein kinase II (CaMKII). CaMKII subsequently translocates to the synapse, where it binds to NMDA-type glutamate receptors and produces potentiation by phosphorylating principal and auxiliary subunits of AMPA-type glutamate receptors. These processes are all localized to stimulated spines and account for the synapse-specificity of LTP. In the later stages of LTP, CaMKII has a structural role in enlarging and strengthening the synapse.

Indexed as

AnimalsCalcium-Calmodulin-Dependent Protein Kinase Type 2HippocampusLong-Term PotentiationPhosphorylationReceptors, AMPAReceptors, N-Methyl-D-AspartateSynapsesCalcium-Calmodulin-Dependent Protein Kinase Type 2Receptors, AMPAReceptors, N-Methyl-D-Aspartate

Identifiers

PMID22334212
PMCPMC4050655
OpenAlexW2013115334

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.